ClinicalTrials.Veeva

Menu
D

Dayton Center for Neurological Disorders | Centerville, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABP-450
Simufilam
Safinamide
Florbetapir
Buntanetap
Galcanezumab
Ofatumumab
Pimavanserin
Droxidopa
Tolebrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 19 total trials
Locations recently updated

A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis (NIMBLE)

This study is researching an experimental combination treatment with pozelimab and cemdisiran, and cemdisiran monotherapy. The study is focused on pa...

Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab
Drug: Pozelimab + Cemdisiran

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

The goal of this open-label extension study is to assess long-term safety and tolerability of simufilam 100 mg in subjects who have completed the RET...

Invitation-only
Alzheimer Disease
Drug: Simufilam

Upper limb essential tremor (UL ET) is a movement disorder characterized by postural and/or kinetic tremor. It can cause difficulty with everyday tas...

Active, not recruiting
Upper Limb Essential Tremor (UL ET)
Drug: Placebo for BOTOX
Biological: BOTOX

Trial sponsors

A
Acadia Pharmaceuticals logo
C
Lilly logo
Sanofi logo
AbbVie logo
A
E
I
Ipsen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems